Literature DB >> 12379314

Molecular understanding of aluminum-induced topological changes in (CCG)12 triplet repeats: relevance to neurological disorders.

Kallur Siddaramaiah Latha1, Suram Anitha, Kosagi Sharaf Jagannatha Rao, Mysore Ananthamurthy Viswamitra.   

Abstract

Recent studies have shown that gene mutations are involved in the pathology of neurological disorders. CCG repeats cause genetic instability and are localized at the 5' end of the non-coding regions of the FMR1 gene in fragile X syndrome. Our studies for the first time showed that aluminum (Al) levels were elevated in the serum samples of fragile X syndrome and also provide evidence for the interaction of aluminum with (CCG)12-repeats. Circular dichroism spectroscopic studies of (CCG)12 indicated B-DNA conformation and in the presence of Al (10(-5) M) CCG repeats attained Z-DNA conformation. Further spectroscopic studies, which included melting profiles, ethidium bromide binding patterns and interaction of Z-DNA specific polyclonal antibodies confirmed the Z-conformation in (CCG)12-repeats in the presence of Al (10(-5) M). It is interesting to mention that Al-induced Z-conformation is stable even after the total removal of Al from CCG by desferoximine, a chelating drug. This is the first report to proof the role of Al in modulating the DNA (CCG repeats) topology and this information provides a clue about the possible involvement of Al at a molecular level in neurological/neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379314     DOI: 10.1016/s0925-4439(02)00133-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Zinc, a neuroprotective agent against aluminum-induced oxidative DNA injury.

Authors:  Neha Singla; D K Dhawan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

2.  Aluminum-Dependent Terminal Differentiation of the Arabidopsis Root Tip Is Mediated through an ATR-, ALT2-, and SOG1-Regulated Transcriptional Response.

Authors:  Caroline A Sjogren; Stephen C Bolaris; Paul B Larsen
Journal:  Plant Cell       Date:  2015-08-28       Impact factor: 11.277

3.  The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases.

Authors:  D K Lahiri; B Maloney; N H Zawia
Journal:  Mol Psychiatry       Date:  2009-11       Impact factor: 15.992

4.  The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps.

Authors:  Debomoy K Lahiri; Bryan Maloney
Journal:  Exp Gerontol       Date:  2010-01-11       Impact factor: 4.032

Review 5.  Models for chromosomal replication-independent non-B DNA structure-induced genetic instability.

Authors:  Guliang Wang; Karen M Vasquez
Journal:  Mol Carcinog       Date:  2009-04       Impact factor: 4.784

6.  Molecular biology research in neuropsychiatry: India's contribution.

Authors:  T S Sathyanarayana Rao; B N Ramesh; P Vasudevaraju; K S J Rao
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

7.  Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses.

Authors:  Masahiro Kawahara; Midori Kato-Negishi
Journal:  Int J Alzheimers Dis       Date:  2011-03-08

8.  Detection of cis- and trans-acting Factors in DNA Structure-Induced Genetic Instability Using In silico and Cellular Approaches.

Authors:  Guliang Wang; Junhua Zhao; Karen M Vasquez
Journal:  Front Genet       Date:  2016-08-02       Impact factor: 4.599

Review 9.  Is aluminum exposure a risk factor for neurological disorders?

Authors:  Elif Inan-Eroglu; Aylin Ayaz
Journal:  J Res Med Sci       Date:  2018-06-06       Impact factor: 1.852

10.  Secondary structural choice of DNA and RNA associated with CGG/CCG trinucleotide repeat expansion rationalizes the RNA misprocessing in FXTAS.

Authors:  Yogeeshwar Ajjugal; Narendar Kolimi; Thenmalarchelvi Rathinavelan
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.